Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: sun who wrote (863)	9/10/1999 10:55:00 AM
From: Bo Didley	Respond to of 5582

OCTOBER...NOVEMBER...DECEMBER...Looking forward to it ! ``The cold category is a $2.3 billion business at retail. When you have a product with ZICAM's potential, it's mandatory to partner with a team of experts who understand how to sell OTC and packaged goods in new and creative ways.' The agency, with significant experience in launching traditional packaged goods products, plans on going beyond the typical media buy for a packaged good product. ``To help introduce a product that has the potential to turn the traditional cold symptom remedy market upside down is a once in a lifetime opportunity,' said Lee Kovel, Creative Director. ``We are thrilled to tackle this groundbreaking product. Expect to see some guerrilla tactics and media usage that would probably make a traditional brand manager faint.' biz.yahoo.com